Mohs Micrographic Funding: How Much Did They Raise & Key Investors

How Much Did Mohs Micrographic Raise?
Funding & Key Investors

Mohs Micrographic has successfully secured a major strategic investment, bringing its total capital accumulation to $150K. This latest infusion of $150K marks a pivotal moment for the Honolulu-based practice, signaling a robust trajectory in the specialized field of dermatologic oncology. By leveraging this financial backing, the organization is positioned to enhance its clinical infrastructure and expand its reach in addressing the high incidence of skin cancer within the Pacific region.

The firm has demonstrated consistent operational maturity, moving beyond initial development phases to establish itself as a cornerstone of advanced surgical care. This capital injection serves as a testament to the practice's commitment to minimally invasive surgical excellence and its role as a leader in cutaneous oncology services.

What is Mohs Micrographic?

Mohs Micrographic

Hospitals & Physicians Clinics

Physicians Clinics

Medical Practice Management

Operating as John D. Boyer, M.D., Inc., the practice specializes in the high-precision treatment of skin cancer, utilizing Mohs micrographic surgery as its primary clinical modality. The organization provides comprehensive care for complex conditions, including basal cell carcinoma, squamous cell carcinoma, and malignant melanoma. By integrating fellowship-trained expertise with a patient-centric approach, the company maintains a competitive advantage in the dermatologic surgery market. Their focus on actinic keratosis and other cutaneous malignancies ensures that they remain at the forefront of regional healthcare, providing essential, life-saving interventions in a specialized, supportive environment.

How much funding has Mohs Micrographic raised?

Mohs Micrographic has raised a total of $150K across 1 funding round:

2020

Debt

$150K

Debt (2020): $150K with participation from PPP

Key Investors in Mohs Micrographic

PPP

Public-Private Partnership

What's next for Mohs Micrographic?

With the recent influx of capital, Mohs Micrographic is expected to prioritize the scaling of its surgical facilities and the integration of advanced diagnostic technologies. The strategic roadmap likely involves deepening its market penetration in Hawaii, where the demand for specialized skin cancer treatment remains elevated. By optimizing its operational workflows and potentially expanding its team of fellowship-trained surgeons, the practice is well-equipped to sustain its growth trajectory. Future initiatives will likely focus on enhancing patient outcomes through continued investment in surgical innovation and the expansion of its educational outreach programs, ensuring the practice remains a vital resource for the community.

See full Mohs Micrographic company page

See More Financial Insights